Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin
Tracy Tabib(University of Pittsburgh), Robert Lafyatis(University of Pittsburgh Medical Center)
Cited by 257
Related Papers
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
|Journal of Clinical Investigation|2015|343